Minimally invasive surgery is performed through small incisions made in the skin. An endoscope is passed through one of the incisions and the image is projected on the screen in the operating room, which assists surgeons to obtain a clear view of the surgical area. Increase in surgeries performed among the geriatric population, advantages of minimally invasive surgeries over traditional open surgeries, and increase in incidence of diseases, such as cardiac disorders, drive the market growth. In addition, rapid technological advancements, increase in awareness of the population, and demand for minimally invasive procedures fuel this growth. However, inadequate quality assurance regarding performance and inappropriate sterilization procedures are expected to restrain the market growth. The global minimally invasive surgical instruments market accounted for $29,444 million in 2016, and is estimated to reach $52,797 million by 2022, growing at a CAGR of 8.7% from 2017 to 2023.
The market is segmented on the basis of product, application, end user, and geography. By product, it is categorized into handheld instruments, electrosurgical instruments, guiding devices, and inflation systems. Applications covered in the study include neurosurgery, cosmetic surgery, urology, obstetrics & gynecology, ophthalmology, cardiovascular, orthopedic surgery, laparoscopy, and other applications. Based on end user, the market is classified into hospitals, ambulatory surgical clinics, and research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS
KEY MARKET SEGMENTS
By End User
List of players profiled in the report
List of other players (These companies are not profiled in the report and same can be included on demand)
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research